Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (51-60 of 164) with videos related to

Pageof 17
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 24, 2019
Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimusAbbie D Leino, Chie Emoto, Tsuyoshi Fukuda, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 22, 2020
Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected RecipientsMark H Eckman, E Steve Woodle, Charuhas V Thakar, et al.
Pharmacotherapy|November 1, 1993
Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5-15 micrograms/mlT H Self, G M Heilker, R R Alloway, et al.
Clinical Transplantation|February 29, 2000
Preliminary experience with midodrine in kidney/pancreas transplant patients with orthostatic hypotensionG C Hurst, K T Somerville, R R Alloway, et al.
Clinical Transplantation|May 17, 2008
Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot studyChristin C Rogers, Rita R Alloway, J Wesley Alexander, et al.
Transplantation Proceedings|January 21, 2017
Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case ReportP Dedhia, A Govil, G Mogilishetty, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Randomized double-blind study of standard versus low-dose OKT3 induction therapy in renal allograft recipientsR Alloway, M Kotb, D K Hathaway, et al.
Clinical Transplantation|March 14, 2014
Desensitization in kidney transplantation: review and future perspectivesBassam G Abu Jawdeh, Madison C Cuffy, Rita R Alloway, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 9, 2016
LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroupsSuphamai Bunnapradist, Lionel Rostaing, Rita R Alloway, et al.
Transplantation Proceedings|April 26, 2005
De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general populationJ F Buell, H T Papaconstantinou, B Skalow, et al.
Pageof 17

Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 24, 2019
Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimusAbbie D Leino, Chie Emoto, Tsuyoshi Fukuda, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 22, 2020
Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected RecipientsMark H Eckman, E Steve Woodle, Charuhas V Thakar, et al.
Pharmacotherapy|November 1, 1993
Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5-15 micrograms/mlT H Self, G M Heilker, R R Alloway, et al.
Clinical Transplantation|February 29, 2000
Preliminary experience with midodrine in kidney/pancreas transplant patients with orthostatic hypotensionG C Hurst, K T Somerville, R R Alloway, et al.
Clinical Transplantation|May 17, 2008
Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot studyChristin C Rogers, Rita R Alloway, J Wesley Alexander, et al.
Transplantation Proceedings|January 21, 2017
Eculizumab and Belatacept for De Novo Atypical Hemolytic Uremic Syndrome Associated With CFHR3-CFHR1 Deletion in a Kidney Transplant Recipient: A Case ReportP Dedhia, A Govil, G Mogilishetty, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1993
Randomized double-blind study of standard versus low-dose OKT3 induction therapy in renal allograft recipientsR Alloway, M Kotb, D K Hathaway, et al.
Clinical Transplantation|March 14, 2014
Desensitization in kidney transplantation: review and future perspectivesBassam G Abu Jawdeh, Madison C Cuffy, Rita R Alloway, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 9, 2016
LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroupsSuphamai Bunnapradist, Lionel Rostaing, Rita R Alloway, et al.
Transplantation Proceedings|April 26, 2005
De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general populationJ F Buell, H T Papaconstantinou, B Skalow, et al.
Pageof 17